drugset / Trial / NCT07248839
A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the pharmacokinetic and safety of BMS-986435 in participants with normal hepatic function and participants with different degrees of hepatic impairment
Timeline
- Start
- 2025-12-15
- Primary completion
- 2026-08-05
- Completion
- 2026-08-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DELOCAMTEN | Small molecule | — | — |
Indications
No indication recorded.